Anne Constantino
Neurology · North Las Vegas, NVNPI 1134197221
Payments from drug & device makers
Across 86 payments — averaging $17.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$467
- Teva Pharmaceuticals USA, Inc.$127
- Cala Health, Inc.$112
- UCB, Inc.$81
- Ipsen Biopharmaceuticals, Inc$66
- EMD Serono, Inc.$61
- plus $593 from 19 others
What the payments were for
- Speaking & faculty fees$342%
- Food & beverage$1,47398%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 29 | $467 |
| Teva Pharmaceuticals USA, Inc. | 4 | $127 |
| Cala Health, Inc. | 2 | $112 |
| UCB, Inc. | 6 | $81 |
| Ipsen Biopharmaceuticals, Inc | 3 | $66 |
| EMD Serono, Inc. | 4 | $61 |
| Lundbeck LLC | 4 | $57 |
| Lilly USA, LLC | 4 | $56 |
| MDD US Operations, LLC | 3 | $49 |
| Acadia Pharmaceuticals Inc | 3 | $48 |
| Acorda Therapeutics, Inc | 2 | $34 |
| AstraZeneca | 2 | $32 |
| Novartis | 2 | $31 |
| Adamas Pharmaceuticals, Inc. | 2 | $31 |
| Supernus Pharmaceuticals, Inc. | 2 | $30 |
| Vertical Pharmaceuticals, LLC | 2 | $30 |
| Merz North America, Inc. | 1 | $30 |
| Zyla Life Sciences, Inc. | 2 | $29 |
| Amneal Pharmaceuticals LLC | 2 | $27 |
| Grifols USA, LLC | 1 | $23 |
| Sunovion Pharmaceuticals Inc. | 2 | $22 |
| Boston Scientific | 1 | $18 |
| Kyowa Kirin, Inc. | 1 | $18 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $16 |
| Amgen | 1 | $13 |
How this compares
$1,507 in reported general payments places this provider in the 50th percentile of 145 neurology providers in Nevada.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levetiracetam | 14 | $1,424 |
| Divalproex Sodium | 12 | $772 |
| Donepezil Hcl | 11 | $212 |
Paid to pharmacies, not to this prescriber.
Other neurology in North Las Vegas
- Sherif HarawayNorth Las Vegas$10K
- Miracle WangsuwanaNorth Las Vegas$9K
- le HuaLas Vegas$5.5M
- Carrie HershLas Vegas$4.5M
- Mehdi AnsariniaLas Vegas$2.9M
- Charles BernickLas Vegas$1.8M
- Zoltan MariLas Vegas$1.4M
- Shanker DixitLas Vegas$1.2M
- Melissa BlochReno$1.1M
- Simon FarrowLas Vegas$592K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.